development pipeline

Pipeline – Drugs for rare diseases

NAME ORIGINATOR INDICATION DEVELOPMENT STATUS
Carbaglu® Orphan Europe
(Recordati)
NAGS deficiency Approved in EU
Pre-registration in US
Carbaglu® Orphan Europe
(Recordati)
Organic acidaemias Pre-registration in EU
Vedrop® Orphan Europe
(Recordati)
Vitamin E deficiency in cystic fibrosis
and chronic cholestasis
Filed with EMEA
Infasurf® Ony Calf derived surfactant for RDS Pre-filing
Stanate® Rockefeller U. / InfaCare Neonatal jaundice, hyperbilirubinemia Phase II / III
Cystagon® Mylan Other indication unrelated to nephropathic cystinosis Phase II / III
Cystadrops® Orphan Europe
(Recordati)
Ocular cystinosis Phase II
Normosang® Orphan Europe
(Recordati)
Hepatic porphyria Approved in EU
Pre-registration in US
© Orphan Europe 2007 | Legal Information | Tools | | Send a friend | Design by Cyim 2007